What Researchers Did
Researchers conducted a descriptive, retrospective review of medical records from 89 patients with diabetic lower-extremity ulcers to compare healing rates across four treatment modalities over eight weeks.
What They Found
All 89 patients with diabetic lower-extremity wounds demonstrated healing over the 8-week period. Patients receiving growth factor therapy alone or in combination with hyperbaric oxygen (HBO) treatments showed the greatest decrease in wound volume, with HBO regimens significantly improving healing.
What This Means for Canadian Patients
Canadian patients with chronic diabetic lower-extremity wounds may benefit from advanced treatments such as growth factor therapy and hyperbaric oxygen. These modalities could potentially improve wound healing outcomes and reduce complications.
Canadian Relevance
This study was conducted in the southwestern United States and does not have a direct Canadian connection.
Study Limitations
As a retrospective review, the study was limited by its observational design and potential for confounding variables.